OR vs IX vs UPBD Stock Comparison

OR Royalties, Orix and Upbound Prices as of Oct 27, 2026 Peers: Industry group
1 more company in this comparison (ECPG) Create a free account to keep reading and compare up to 10 companies.
OR OR Royalties Inc.
$34.08 -4.8% 1M +7.5% 1Y
Market cap
$6.35B
P/E
22.4x
Revenue (TTM)
$362.74M
Div. yield
–
Specialty Finance Financial Services
5 wins
IX Orix Corp
$36.91 -5.9% 1M +48.2% 1Y
Market cap
$41.15B
P/E
10.3x
Revenue (TTM)
$55.33B
Div. yield
–
Specialty Finance Financial Services
4 wins
UPBD Upbound Group, Inc.
$16.95 +5.3% 1M -27.2% 1Y
Market cap
$983.67M
P/E
10.9x
Revenue (TTM)
$4.74B
Div. yield
–
Specialty Finance Financial Services
2 wins

Head to Head

11 decided of 12

OR Royalties leads on 5 of the 12 questions below (OR Royalties 5, Orix 4, Upbound 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionORIXUPBDLeader
Larger companyMarket capitalisation $6.35B $41.15B $983.67M IX
Cheaper on earningsLower P/E, profitable companies only 22.4x 10.3x 10.9x IX
Cheaper on forward earningsLower price / next fiscal year consensus EPS 28.2x 8.0x 3.9x UPBD
Faster revenue growthRevenue growth, trailing twelve months +69.5% +2.8% +5.9% OR
More profitableNet margin, trailing twelve months 78.0% 7.3% 1.9% OR
Better return on capitalReturn on invested capital — 3.0% 7.8% UPBD
Less leveragedLower net debt / EBITDA 0.4x — 0.8x OR
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +7.5% +48.2% -27.2% IX
Better 5-year returnAnnualised price return, 5 years +21.6%/yr +13.3%/yr -20.6%/yr OR
Less volatileAnnualised volatility, 1 year 46.5% 28.7% 45.0% IX
Higher overall scoreMean of the five percentile scores vs peers 67/100 51/100 63/100 OR

Percentile Scorecard

ORIXUPBD

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisORIXUPBD
Valuation 35 #111 of 169 57 #73 of 169 96 #8 of 169
Growth 96 #8 of 160 76 #39 of 160 71 #47 of 160
Profitability 100 #1 of 149 60 #61 of 149 62 #57 of 149
Financial Health 98 #4 of 158 52 #77 of 158 53 #75 of 158
Shareholder Returns 6 #128 of 136 10 #123 of 136 31 #94 of 136
Overall 67 51 63
  • OR ranked among 174 companies in Lending and Credit
  • IX ranked among 174 companies in Lending and Credit
  • UPBD ranked among 174 companies in Lending and Credit

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodORIXUPBDSPY
1 month -4.8%-5.9%+5.3% -0.2%
3 months +15.8%-5.8%-21.5% +3.9%
6 months -9.3%+13.5%-11.1% +8.2%
Year to date -3.7%+26.3%-3.5% +12.9%
1 year +7.5%+48.2%-27.2% +12.3%
3 years +176.0%+106.0%-32.9% +87.4%
3 years, per year +40.3%+27.3%-12.5% +23.3%
5 years +165.4%+86.6%-68.4% +67.9%
5 years, per year +21.6%+13.3%-20.6% +10.9%
10 years +225.8%+138.6%+74.6% +261.1%
10 years, per year +12.5%+9.1%+5.7% +13.7%

Risk

MeasureORIXUPBDSPY
Volatility, 1Y 46.5%28.7%45.0% 12.7%
Downside volatility, 1Y 50.3%28.1%46.6% 12.7%
Beta vs S&P 500, 1Y 1.641.011.28 1.00
Return / volatility, 1Y 0.161.68-0.60 0.97
Max drawdown, 5Y -41.2%-39.0%-72.2% -25.4%
From 52-week high -28.6%-10.7%-28.2% -1.2%
52-week high $47.73$41.31$23.60 $779.14
52-week low $28.05$24.22$15.36 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleORIXUPBD
P/E now vs peer median 22.6xmedian 11.1x 10.3xmedian 11.1x 10.9xmedian 11.1x
P/S now vs peer median 17.6xmedian 2.6x 0.7xmedian 2.6x 0.2xmedian 2.6x
EV/EBITDA now vs peer median 20.1xmedian 13.5x —median 13.5x 1.4xmedian 13.5x
P/FCF now vs peer median 21.0xmedian 7.0x —median 7.0x 2.8xmedian 7.0x
P/B now vs peer median —median 0.7x 1.4xmedian 0.7x 1.3xmedian 0.7x
PEG now vs peer median 0.36median 0.32 0.40median 0.32 0.04median 0.32

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsORIXUPBD
Revenue $362.74M $55.33B $4.74B
Gross profit $307.80M $13.35B $2.33B
Operating income $279.97M $3.05B $241.70M
Net income $283.06M $4.10B $90.34M
Free cash flow $303.17M – $355.95M
EPS (diluted) $1.50 $3.58 $1.54
Cash & equivalents $75.61M $5.98B $105.30M
Total debt $384.77M $38.96B $5.98B
Shares (diluted) 189.15M 1.12B 58.71M
Enterprise value $5.98B $9.87B $552.40M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricORIXUPBD
P/E 22.6x 10.3x 10.9x
P/FCF 21.0x – 2.8x
P/Operating cash flow 21.0x – 2.3x
P/S 17.6x 0.7x 0.2x
P/B – 1.4x 1.3x
P/Tangible book – 1.4x 2.4x
EV/EBITDA 20.1x – 1.4x
EV/EBIT 23.3x 24.4x 9.5x
EV/Revenue 18.0x 1.3x 0.5x
EV/FCF 21.5x – 6.5x
EV/Operating cash flow 21.5x – 5.4x
PEG (3Y EPS CAGR) 0.36 0.40 0.04

Growth

14 metrics
MetricORIXUPBD
Revenue growth (1Y) 69.5% 2.8% 5.9%
Revenue CAGR (3Y) 27.3% 7.3% 5.8%
Gross profit growth (1Y) 76.6% 1,837% 8.9%
Gross profit CAGR (3Y) 36.1% -24.8% 5.0%
Operating income growth (1Y) 91.4% 24.1% -7.9%
Operating income CAGR (3Y) 44.0% 7.6% 23.5%
Net income growth (1Y) 260.5% 62.7% -11.5%
Net income CAGR (3Y) 61.8% 23.4% 303.4%
EPS growth (1Y) 260.4% 64.4% -11.6%
EPS CAGR (3Y) 62.7% 25.9% 295.6%
Operating cash flow growth (1Y) 82.0% – 94.9%
Operating cash flow CAGR (3Y) 31.3% – 9.6%
Free cash flow growth (1Y) 82.0% – 123.2%
Free cash flow CAGR (3Y) 31.3% – 9.5%

Profitability

14 metrics
MetricORIXUPBD
Gross margin 84.9% 24.1% 49.1%
EBITDA margin 89.6% – 35.5%
Operating margin 77.2% 5.5% 5.1%
Pretax margin 91.1% 11.1% 2.7%
Net margin 78.0% 7.3% 1.9%
FCF margin 83.6% – 7.5%
Operating cash flow margin 83.6% – 9.0%
Return on equity – 14.1% 12.5%
Return on assets – 3.6% 2.9%
Return on invested capital – 3.0% 7.8%
Return on capital employed – – –
Asset turnover – 0.5x 1.5x
Cash conversion (OCF / net income) 1.1x – 4.7x
Stock comp / revenue 2.2% – 1.1%

Financial Health

11 metrics
MetricORIXUPBD
Debt / assets – 34.6% 45.9%
Debt / equity – 1.3x 1.9x
Net debt / EBITDA 0.4x – 0.8x
Debt / FCF 0.7x – 4.0x
Liabilities / assets – 73.8% 76.4%
Equity / assets – 26.2% 23.6%
Interest coverage 50.0x 2.4x 2.2x
Current ratio – – –
Quick ratio – – –
Cash ratio – – –
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricORIXUPBD
Dividend yield 0.8% 1.1% 9.2%
Net buyback yield – – -0.1%
Shareholder yield 0.8% 1.1% 9.1%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusORIXUPBD
Forward P/E 28.2xFY2026 8.0xFY2026 3.9xFY2026
EPS, next fiscal year $1.21FY2026 $4.59FY2026 $4.36FY2026
EPS growth, next FY +37.5%FY2026 +80.7%FY2026 +5.6%FY2026
EPS growth, the year after +13.2% -27.7% +8.9%
Revenue, next fiscal year $404.61MFY2026 $22.87BFY2026 $5.00BFY2026
Revenue growth, next FY +45.9%FY2026 +8.2%FY2026 +6.3%FY2026
Revenue growth, the year after +6.8% -3.2% -4.8%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersORIXUPBD
Held by institutions 68.0% 3.3% 99.3%
Institutions holding 244 318 256
Change in shares held, QoQ -2.1% +9.5% +3.3%
Institutions buying 116 209 146
Institutions selling 84 57 69
Buyers to sellers 1.38 3.67 2.12

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ORIXUPBD
OR 1.00 0.32 0.05
IX 0.32 1.00 0.08
UPBD 0.05 0.08 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, OR, IX and UPBD?

Orix (IX) is the largest by market capitalisation: OR Royalties (OR) $6.35B, Orix (IX) $41.15B, Upbound (UPBD) $983.67M.

Which stock is cheaper, OR, IX and UPBD?

Orix (IX) trades on the lowest price-to-earnings ratio (OR Royalties (OR) 22.4x, Orix (IX) 10.3x, Upbound (UPBD) 10.9x). On next year's consensus earnings, Upbound (UPBD) is cheapest (OR Royalties (OR) 28.2x, Orix (IX) 8.0x, Upbound (UPBD) 3.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

OR Royalties (OR) grew revenue fastest over the trailing twelve months: OR Royalties (OR) +69.5%, Orix (IX) +2.8%, Upbound (UPBD) +5.9%.

Which company is more profitable?

OR Royalties (OR) has the highest net margin (OR Royalties (OR) 78.0%, Orix (IX) 7.3%, Upbound (UPBD) 1.9%). On return on invested capital, Upbound (UPBD) leads (Orix (IX) 3.0%, Upbound (UPBD) 7.8%).

Which stock has performed better?

Over the past year Orix (IX) returned the most: OR Royalties (OR) +7.5%, Orix (IX) +48.2%, Upbound (UPBD) -27.2%. Over five years, OR Royalties (OR) compounded fastest (OR Royalties (OR) +21.6%/yr, Orix (IX) +13.3%/yr, Upbound (UPBD) -20.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Orix (IX) has been the steadiest (OR Royalties (OR) 46.5%, Orix (IX) 28.7%, Upbound (UPBD) 45.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, OR, IX and UPBD?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, OR Royalties (OR) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.